» Articles » PMID: 1551208

Neutralization of Endogenous Tumor Necrosis Factor Ameliorates the Severity of Myosin-induced Myocarditis

Overview
Journal Circ Res
Date 1992 Apr 1
PMID 1551208
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor (TNF) and interferon gamma (IFN-gamma) are pluripotent cytokines and have multiple functions during the inflammatory response. Using a murine model of autoimmune myocarditis, we studied the role of TNF and IFN-gamma in myocardial inflammation. Neutralizing monoclonal antibodies against TNF-alpha/beta and IFN-gamma were administered to myosin-immunized A/J mice to assess the effect on the severity of myocardial inflammation. Anti-TNF treatment significantly reduced the severity of myocarditis compared with rat immunoglobulin G or saline controls (p less than 0.0007) when given before myosin immunization. Myosin-specific lymph node T-cell proliferation studies showed no difference in the proliferative response between the anti-TNF-treated mice and controls. Administration of anti-TNF to mice after myosin immunization had no effect on the severity of inflammation. This suggests that TNF is an important mediator early in the pathogenesis of myocardial inflammation in this model of myocarditis. Neutralization of IFN-gamma significantly increased the severity of myocarditis compared with rat immunoglobulin G and saline controls (p less than 0.0065), suggesting that IFN-gamma may function as an important regulatory cytokine early in the pathogenesis of myocardial inflammation. Understanding the functions of cytokines during the inflammatory response to myocardial injury may provide important information on possible methods to limit myocardial damage.

Citing Articles

TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells.

Rolski F, Tkacz K, Weglarczyk K, Kwiatkowski G, Pelczar P, Jazwa-Kusior A Cardiovasc Res. 2023; 120(1):82-94.

PMID: 37879102 PMC: 10898940. DOI: 10.1093/cvr/cvad158.


Modulation of TLR4/NFκB Pathways in Autoimmune Myocarditis.

Interdonato L, Impellizzeri D, DAmico R, Cordaro M, Siracusa R, DAgostino M Antioxidants (Basel). 2023; 12(8).

PMID: 37627502 PMC: 10451772. DOI: 10.3390/antiox12081507.


Transcriptomic Analysis of Inflammatory Cardiomyopathy Identifies Molecular Signatures of Disease and Informs Prediction of a Network-Based Rationale for Therapy.

Singh K, Fang H, Davies G, Wright B, Lockstone H, Williams R Front Immunol. 2021; 12:640837.

PMID: 33746983 PMC: 7973371. DOI: 10.3389/fimmu.2021.640837.


Complexity of TNF-α Signaling in Heart Disease.

Rolski F, Blyszczuk P J Clin Med. 2020; 9(10).

PMID: 33053859 PMC: 7601316. DOI: 10.3390/jcm9103267.


Myocarditis in Humans and in Experimental Animal Models.

Blyszczuk P Front Cardiovasc Med. 2019; 6:64.

PMID: 31157241 PMC: 6532015. DOI: 10.3389/fcvm.2019.00064.